The Challenge of Getting it Just Right: Optimizing Long-Term Antithrombotic Therapy After Acute Coronary Syndrome.
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: cruff@partners.org.
Christian T
CT
Ruff
D054058:Acute Coronary Syndrome / Q000175:diagnosis* / Q000188:drug therapy*; D065427:Factor Xa Inhibitors / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage*; D011720:Pyrazoles / Q000008:administration & dosage*; D011728:Pyridones / Q000008:administration & dosage*
D065427:Factor Xa Inhibitors; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D011720:Pyrazoles; D011728:Pyridones
acute coronary syndrome; anticoagulants; aspirin; factor Xa inhibitors; platelet aggregation inhibitors; secondary prevention